Clinical Trial Update: Aerosolized Aldesleukin in Treating Patients With Lung Metastases [Phase 1]

View source ↗

Summary

Phase 1 study evaluating aerosolized aldesleukin (interleukin-2) in patients with cancers that have metastasized to the lung, including melanoma, osteosarcoma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Lung Metastases
• Melanoma
• Osteosarcoma
• Renal Cell Carcinoma
• Sarcoma

Drugs mentioned

• Aldesleukin (interleukin-2)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Malignant Neoplasm in the Lung, Metastatic Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING